Skip to content
Free updates Login
SSCBankingUPSC & State PSC

CBN and PHARMEXCIL MoU on legitimate pharma exports

26 August 20261 min read
ECONOMYCBN andPHARMEXCIL MoUon legitimatepharma exports26 August 2026safalsetu.com

Why in the news

Two bodies signed an agreement in August 2026 to support lawful drug exports while blocking misuse of controlled substances.

Key facts

  • Signatories: Central Bureau of Narcotics (CBN) and PHARMEXCIL.
  • Aims: boost legitimate pharmaceutical exports and stop diversion of controlled substances.
  • Both will develop a Voluntary Code of Conduct (VCC).
  • Cooperation covers workshops, awareness programmes and sharing of regulatory information.

Significance

  • Links export promotion with safeguards against diversion of controlled substances.

Exam angle

  • Likely question: what will CBN and PHARMEXCIL jointly develop? Answer: a Voluntary Code of Conduct.
  • Related terms: MoU, controlled substances, diversion, pharma exports.

Test yourself

1. What will CBN and PHARMEXCIL jointly develop under their MoU?

They will develop a Voluntary Code of Conduct (VCC).

2. Which two organisations signed the MoU on pharma exports in August 2026?

The Central Bureau of Narcotics and PHARMEXCIL signed it.

3. What risk does the CBN-PHARMEXCIL MoU seek to prevent?

It aims to prevent diversion of controlled substances.

This topic is part of Daily Current Affairs 26 August 2026 (26 topics).

All topics of the dayDay quizAugust 2026

Read more